CTCE-0214

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCTCE-0214
Drug Alias NameCTCE-0214CT-0214
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBritish Canadian Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBritish Canadian Biosciences
Active IndicationsN/A
Inactive IndicationsHematopoietic stem cell transplantation (HSCT)

Other Information

ATC CodeN/A
Related LinksN/A